SE447117B - Kristallint hemisyrasalt av en molekyl 7beta-/2-(2-aminotiazol-4-yl)-(z)-2metoxiiminoacetamido/-3-/(1-metyl-1h-tetrazol-5-yl)tiometyl/-cef-3-em-4-karboxylsyra och en halv molekyl hcl eller hbr - Google Patents

Kristallint hemisyrasalt av en molekyl 7beta-/2-(2-aminotiazol-4-yl)-(z)-2metoxiiminoacetamido/-3-/(1-metyl-1h-tetrazol-5-yl)tiometyl/-cef-3-em-4-karboxylsyra och en halv molekyl hcl eller hbr

Info

Publication number
SE447117B
SE447117B SE7909998A SE7909998A SE447117B SE 447117 B SE447117 B SE 447117B SE 7909998 A SE7909998 A SE 7909998A SE 7909998 A SE7909998 A SE 7909998A SE 447117 B SE447117 B SE 447117B
Authority
SE
Sweden
Prior art keywords
hcl
salt
molecule
carboxylic acid
hbr
Prior art date
Application number
SE7909998A
Other languages
English (en)
Swedish (sv)
Other versions
SE7909998L (sv
Inventor
H Natsugari
I Mikami
M Ochiai
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of SE7909998L publication Critical patent/SE7909998L/
Publication of SE447117B publication Critical patent/SE447117B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7909998A 1978-12-11 1979-12-04 Kristallint hemisyrasalt av en molekyl 7beta-/2-(2-aminotiazol-4-yl)-(z)-2metoxiiminoacetamido/-3-/(1-metyl-1h-tetrazol-5-yl)tiometyl/-cef-3-em-4-karboxylsyra och en halv molekyl hcl eller hbr SE447117B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15337778A JPS5579393A (en) 1978-12-11 1978-12-11 Cephalosporin derivative and its preparation

Publications (2)

Publication Number Publication Date
SE7909998L SE7909998L (sv) 1980-06-12
SE447117B true SE447117B (sv) 1986-10-27

Family

ID=15561123

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7909998A SE447117B (sv) 1978-12-11 1979-12-04 Kristallint hemisyrasalt av en molekyl 7beta-/2-(2-aminotiazol-4-yl)-(z)-2metoxiiminoacetamido/-3-/(1-metyl-1h-tetrazol-5-yl)tiometyl/-cef-3-em-4-karboxylsyra och en halv molekyl hcl eller hbr

Country Status (18)

Country Link
US (1) US4298607A (de)
JP (1) JPS5579393A (de)
BE (1) BE880518A (de)
CA (1) CA1128499A (de)
CH (1) CH646437A5 (de)
DE (1) DE2949485A1 (de)
DK (1) DK159785C (de)
ES (1) ES8100299A1 (de)
FR (1) FR2444042A1 (de)
GB (1) GB2036746B (de)
GR (1) GR74078B (de)
HK (1) HK9486A (de)
IT (1) IT1126514B (de)
MY (1) MY8500456A (de)
NL (1) NL190487C (de)
NO (1) NO158219C (de)
SE (1) SE447117B (de)
SG (1) SG93185G (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78221B (de) * 1980-02-01 1984-09-26 Ciba Geigy Ag
US4400503A (en) * 1981-10-30 1983-08-23 Eli Lilly And Company Purification of syn-7-[[(2-amino-4-thiazolyl)(methoxyimino) acetyl]amino]-3-methyl-3-cephem-4-carboxylic acid
US4594417A (en) * 1981-10-30 1986-06-10 Eli Lilly Company Crystalline antibiotic salt
US4902683A (en) * 1984-10-25 1990-02-20 The Upjohn Company Crystalline cephalosporin hydrohalide salts
EP0638573A1 (de) * 1993-08-10 1995-02-15 Lucky Ltd. Kristalline Hydrate eines Cephalosporins und Verfahren zu ihrer Herstellung
ATE440101T1 (de) 2003-03-27 2009-09-15 Basilea Pharmaceutica Ag Cephalosporin in kristalliner form

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
FR2345153A1 (fr) * 1976-03-25 1977-10-21 Roussel Uclaf Nouvelles alcoyloximes derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
GB1576625A (en) * 1976-04-12 1980-10-08 Fujisawa Pharmaceutical Co Syn isomer 3,7 disubstituted 3 cephem 4 carboxylic acid compounds and processes for the preparation thereof
JPS603314B2 (ja) * 1976-08-31 1985-01-26 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
BE880518A (fr) 1980-06-10
NO158219C (no) 1988-08-03
ES486680A0 (es) 1980-11-01
GB2036746B (en) 1983-02-09
SG93185G (en) 1987-03-27
NO793989L (no) 1980-06-12
NL7908869A (nl) 1980-06-13
DK524579A (da) 1980-06-12
GR74078B (de) 1984-06-06
DK159785B (da) 1990-12-03
DE2949485A1 (de) 1980-06-19
SE7909998L (sv) 1980-06-12
MY8500456A (en) 1985-12-31
US4298607A (en) 1981-11-03
DE2949485C2 (de) 1989-06-08
FR2444042A1 (fr) 1980-07-11
NL190487B (nl) 1993-10-18
ES8100299A1 (es) 1980-11-01
CA1128499A (en) 1982-07-27
GB2036746A (en) 1980-07-02
IT1126514B (it) 1986-05-21
CH646437A5 (de) 1984-11-30
NL190487C (nl) 1994-03-16
NO158219B (no) 1988-04-25
JPS5579393A (en) 1980-06-14
FR2444042B1 (de) 1983-06-24
JPS636552B2 (de) 1988-02-10
HK9486A (en) 1986-02-14
DK159785C (da) 1991-04-22
IT7927924A0 (it) 1979-12-07

Similar Documents

Publication Publication Date Title
KR840001776B1 (ko) 세프타지딤 펜타하이드레이트의 제조방법
RU2118959C1 (ru) ГИДРОХЛОРИД 7β-[(Z)-2-(2-АМИНО-4-ТИАЗОЛИЛ)-2-ГИДРОКСИИМИНОАЦЕТАМИДО]-3-(1,2,3-ТРИАЗОЛ-4-ИЛ)-ТИОМЕТИЛТИО-3-ЦЕФЕМ-4-КАРБОНОВОЙ КИСЛОТЫ, ЕГО КРИСТАЛЛОГИДРАТ И СПОСОБ ИХ ПОЛУЧЕНИЯ
SE449749B (sv) Bis-estrar av metandiol med penicilliner och penicillansyra-1,1-dioxid
US4609653A (en) Crystalline cephem-acid addition salts and processes for their preparation
SE437522B (sv) (6r,7r)-7-/2-(2-amino-4-tiazolyl)-2-(z-metoxiimino)-acetamido/-3-(substituerad tiometyl)-cefalosporinsyra samt legre alkanoylalkyl estar/etrar derav
JPS6153359B2 (de)
EP0131147B2 (de) Kristallines Amoxycillin-Salz
JP4480396B2 (ja) カルバペネム化合物の製造方法
SE447117B (sv) Kristallint hemisyrasalt av en molekyl 7beta-/2-(2-aminotiazol-4-yl)-(z)-2metoxiiminoacetamido/-3-/(1-metyl-1h-tetrazol-5-yl)tiometyl/-cef-3-em-4-karboxylsyra och en halv molekyl hcl eller hbr
BG60439B2 (bg) Твърда цефалоспоринова сол
US20020193587A1 (en) Penicillin crystal and process for producing the same
DK148022B (da) Fremgangsmaade til fremstilling af alfa-formen af krystallinsk natrium-o-formyl-cefamandol
KR910010002B1 (ko) 소듐 세펨 카르복실레이트의 결정의 제조방법
DE2739448A1 (de) 7-substituierte aminoacetamido- oxadethiacephalosporine, verfahren zu deren herstellung und deren verwendung bei der behandlung bakterieller erkrankungen
JP2003300985A (ja) セフェム化合物
KR100696422B1 (ko) 항생물질로서 사이클릭 아미노구아니딘 치환체를 가진세팔로스포린
KR880001299B1 (ko) 7β-(2D-2-아미노-2-카르복시-에틸티오아세트아미드)-7α-메톡시-3-(1-메틸-1H-테트라졸-5-일)-티오메틸-3-세펨-4-카르본산나트륨염 7수화물의 제조방법
HU186999B (en) Process for the preparation of cephem-caraoxylic acid containing heterocyclic group in 3-position
US4668782A (en) Anhydrous crystalline or crystalline hemihydrate monohydrate or trihydrate of cephalosporin derivative
KR880000181B1 (ko) 세팔로스포린 유도체의 결정성염의 제조방법
US4497811A (en) 1-Oxadethiacephalosporin compound and antibacterial agent containing the _same
IE47929B1 (en) Substituted imidazolidinyl-3-chloro-3-cephem-4-carboxylic acids
KR100463920B1 (ko) 신규 세프디토렌 피복실 메지틸렌 설폰산염 및 그 제조방법
US4173703A (en) Preparation of carbamates
US3879384A (en) 7-{8 2-(1-and 2 cyclopenten-1-yl)acetamido{9 cephalosporanic acids

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7909998-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7909998-2

Format of ref document f/p: F